NMDAζ1 (phospho Ser890) Polyclonal Antibody

货号：ES5648
价格：面议
点击：2201

产品介绍

抗体信息

应用	IHC-p;IF/ICC;ELISA
反应种属	Human;Mouse;Rat
别称	GRIN1; NMDAR1; Glutamate [NMDA] receptor subunit zeta-1; N-methyl-D-aspartate receptor subunit NR1; NMD-R1

【仅供科学研究使用】

相关产品:

产品名称	点击数
Anti-Sarilumab Neutralizing Recombinant Antibody \|抗萨瑞鲁单抗中和重组抗体(靶标：萨瑞鲁单抗中和抗体)	273
Anti-Sarilumab Neutralizing Recombinant Antibody \|抗萨瑞鲁单抗中和重组抗体(靶标：萨瑞鲁单抗中和抗体)	236
Anti-Sarilumab Neutralizing Recombinant Antibody \|抗萨瑞鲁单抗中和重组抗体(靶标：萨瑞鲁单抗中和抗体)	230
Anti-Sarilumab Neutralizing Recombinant Antibody \|抗萨瑞鲁单抗中和重组抗体(靶标：萨瑞鲁单抗中和抗体)	270
Anti-Durvalumab Non-Neutralizing Recombinant Antibody \|程度伐利尤单抗非中和重组抗体(靶标：度伐利尤单抗非中和抗体)	510
Anti-Durvalumab Non-Neutralizing Recombinant Antibody \|抗度伐利尤单抗非中和重组抗体(靶标：度伐利尤单抗非中和抗体)	475
Anti-Durvalumab Neutralizing Recombinant Antibody \|抗度伐利尤单抗中和重组抗体(靶标：度伐利尤单抗中和抗体)	310
Anti-Durvalumab Neutralizing Recombinant Antibody \|抗度伐利尤单抗中和重组抗体(靶标：度伐利尤单抗中和抗体)	344
Anti-Durvalumab Neutralizing Recombinant Antibody \|抗度伐利尤单抗中和重组抗体(靶标：度伐利尤单抗中和抗体)	293
Anti-Durvalumab Neutralizing Recombinant Antibody \|抗度伐利尤单抗中和重组抗体(靶标：度伐利尤单抗中和抗体)	271
Anti-Atezolizumab Non-Neutralizing Recombinant Antibody \|抗阿替利珠单抗非中和重组抗体(靶标：阿替利珠单抗非中和抗体)	325
Anti-Atezolizumab Non-Neutralizing Recombinant Antibody \|抗阿替利珠单抗非中和重组抗体(靶标：阿替利珠单抗非中和抗体)	277
Anti-Atezolizumab Neutralizing Recombinant Antibody \|抗阿替利珠单抗中和重组抗体(靶标：阿替利珠单抗中和抗体)	270
Anti-Atezolizumab Neutralizing Recombinant Antibody \|抗阿替利珠单抗中和重组抗体(靶标：阿替利珠单抗中和抗体)	355
Anti-Panitumumab Non-Neutralizing Recombinant Antibody \|抗帕尼单抗非中和重组抗体(靶标：帕尼单抗非中和抗体)	452
Anti-Panitumumab Non-Neutralizing Recombinant Antibody \|抗帕尼单抗非中和重组抗体(靶标：帕尼单抗非中和抗体)	275
Anti-Panitumumab Non-Neutralizing Recombinant Antibody \|抗帕尼单抗非中和重组抗体(靶标：帕尼单抗非中和抗体)	226
Anti-Panitumumab Neutralizing Recombinant Antibody \|抗帕尼单抗中和重组抗体(靶标：帕尼单抗中和抗体)	207
Anti-Panitumumab Neutralizing Recombinant Antibody \|抗帕尼单抗中和重组抗体(靶标：帕尼单抗中和抗体)	191
Anti-Panitumumab Neutralizing Recombinant Antibody \|抗帕尼单抗中和重组抗体(靶标：帕尼单抗中和抗体)	202

在线客服

QQ交谈

销售热线：
15898894496(同微信)
我要留言
周一至周五每天9:00-17:00